Lynx1 Capital Management LP

13F Holdings History for Neuphoria Therapeutics Inc. - Common Stock, par value $0.00001 per share (NEUP)

Symbol: NEUP on Nasdaq
Investment type: Equity / Common Stock, par value $0.00001 per share
Latest Disclosed Ownership: 875K shares
Security Ownership: 16.3%

Shares, Excluding Options vs Price

Value, Excluding Options

Lynx1 Capital Management LP ownership in Neuphoria Therapeutics Inc. Common Stock, par value $0.00001 per share (NEUP)

2025-11-28 - Lynx1 Capital Management LP has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 875K shares of Neuphoria Therapeutics Inc. Common Stock, par value $0.00001 per share (NEUP). This represents 16.3% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Price	Form	Report date	Filed at
Lynx1 Capital Management LP	16.3%		$4.12M	875K	$4.71	13D/A	11/28/2025	28 Nov 2025 09:09:08
Lynx1 Capital Management LP	16.3%	-37.8%	$4.12M	875K	$4.71	13D/A	11/18/2025	18 Nov 2025 08:25:56
Lynx1 Capital Management LP	26.5%	-28.6%	$10.4M	875K	$11.86	13D/A	11/9/2025	10 Nov 2025 14:33:07
Lynx1 Capital Management LP	37.1%		$10.4M	875K	$11.86	13D	10/21/2025	23 Oct 2025 19:52:36

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025		-0.09%	$0	0	-45,806	-100%		Q3 2025
6/30/2025	0.09%		$325K	45.8K			$7.10	Q2 2025
3/31/2025	0.09%		$264K	45.8K			$5.76	Q1 2025
12/31/2024	0.06%	+0.06%	$157K	45.8K	+45,806	NEW	$3.43	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.